http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
BD to Present at Wells Fargo 2025 Healthcare Conference
-
BD Reports Third Quarter Fiscal 2025 Financial Results
-
BD Businesses Become First in MedTech to Achieve HIRC's Diamond Badge Across All Supply Chain Resiliency Categories
-
BD to invest $35 million in Nebraska facility expansion
-
BD to Invest $35 Million in Nebraska Facility to Expand Prefilled Flush Syringe Manufacturing to Support U.S. Health Care
-
BD Aims to Save Lives by Empowering Women with Choice and Access to Cervical Cancer Screening Self-Collected At Home
-
BD receives FDA clearance for rapid COVID-19 test
-
BD Receives FDA 510(k) Clearance for Rapid Point-of-Care COVID-19 Test
-
BD begins first pharma-sponsored trial for Libertas wearable injector
-
BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs
-
BD Board Declares Dividend
-
Waters to merge with BD's biosciences unit in $17.5 billion deal
-
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
-
BD names Bilal Muhsin as executive vice president and president of new segment
-
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment
-
BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
-
BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference
-
Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'
-
BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
-
BD to Announce Financial Results for its Third Quarter of Fiscal 2025
-
BD Reports Second Quarter Fiscal 2025 Financial Results
-
BD to Present at Bank of America Securities Health Care Conference
-
BD Board Declares Dividend
-
Becton Dickinson (BDX) Launches Bioabsorbable Mesh Designed for Umbilical Hernia Repair
-
BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair
-
BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support
-
BD to Announce Financial Results for its Second Quarter of Fiscal 2025
-
BD Named One of America's Most Innovative Companies by Fortune
-
Becton Dickinson (BDX) Appoints Gregory J. Hayes to its Board
-
BD Names Gregory J. Hayes to Board of Directors
-
Becton Dickinson (BDX) Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE Scaffold in Breast Implant Revision Surgery
-
BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE™ Scaffold in Breast Implant Revision Surgery
-
BD to Present at Investor Healthcare Conferences
-
Becton Dickinson (BDX) to Separate Biosciences and Diagnostic Solutions Business
-
BD Reports First Quarter Fiscal 2025 Financial Results
-
BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value
-
Becton Dickinson (BDX) Announces Share Buyback, Declares Dividends
-
BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25
-
BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development
-
Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care
-
BD to Announce Financial Results for its First Quarter of Fiscal 2025
-
Becton Dickinson (BDX) Boosts U.S. Manufacturing of Critical Medical Devices
-
BD Boosts U.S. Manufacturing of Critical Medical Devices
-
New ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening
-
Becton Dickinson (BDX) names Pamela Spikner CAO and controller
-
BD Names Pamela Spikner as Chief Accounting Officer and Controller
-
New Survey Finds Women Are Skipping Their OB/GYN Exams, Increasing Risks for Cervical Cancer
-
BD To Host Virtual 2025 Annual Meeting of Shareholders
-
Becton Dickinson (BDX) and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
-
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
